Eculizumab in treatment for complement-mediated thrombotic microangiopathy associated with acute pancreatitis
EXCLI Journal · 18.12.2025 · 24 · 1802-1803
DOI: 10.17179/excli2025-8881 ↗Kurz gefasst
Leserbrief in der Zeitschrift EXCLI Journal, online erschienen am 18.12.2025. Verfasst von Shruti Shettigar und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology, Hypertension, and Renal Transplantation, University of Florida -College of Medicine, Gainesville, Florida, USA. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Division of Nephrology, Hypertension, and Renal Transplantation, University of Florida -College of Medicine, Gainesville, Florida, USA.
- Rahul International School, Mira Road, Thane, Maharashtra, India.
Zitieren
APA
Shettigar, S., Jadvani, R., Doshi, D., & Shah, C. V. (2025). Eculizumab in treatment for complement-mediated thrombotic microangiopathy associated with acute pancreatitis. EXCLI Journal, 24, 1802-1803. https://doi.org/10.17179/excli2025-8881
Vancouver
Shettigar S, Jadvani R, Doshi D, Shah CV. Eculizumab in treatment for complement-mediated thrombotic microangiopathy associated with acute pancreatitis. EXCLI Journal. 2025;24:1802-1803. doi:10.17179/excli2025-8881
BibTeX
@article{Shettigar2025,
author = {Shettigar, Shruti and Jadvani, Rutvikkumar and Doshi, Dwij and Shah, Chintan V},
title = {Eculizumab in treatment for complement-mediated thrombotic microangiopathy associated with acute pancreatitis},
journal = {EXCLI Journal},
year = {2025},
volume = {24},
pages = {1802--1803},
doi = {10.17179/excli2025-8881}
}
EUVIMED